Downsizing update from DCS to PLC+SCADA for pharmaceuticals
Free yourself from the high maintenance costs and manufacturer dependence of DCS!
In the pharmaceutical industry, accurate recording and management of manufacturing processes are essential for product quality assurance and regulatory compliance. In particular, the reliability of manufacturing records is directly linked to the safety and efficacy of pharmaceuticals, necessitating high levels of precision and traceability. Aging DCS systems can pose challenges in meeting these demands due to issues such as the end of parts supply, rising maintenance costs, and expensive, prolonged downtime caused by manufacturer dependency during system upgrades. Our SCADA software + PLC renewal plan will complete the system replacement, including modifications to existing panels and wiring conversions, based on on-site expertise. By adopting open technologies, we also ensure future scalability, supporting improvements in the reliability of manufacturing records and operational efficiency in the pharmaceutical industry. 【Use Cases】 - Upgrading from DCS to PLC+SCADA in manufacturing lines - Renewal of aging control systems - Breaking free from manufacturer dependency - Manufacturing environments including explosion-proof areas 【Benefits of Implementation】 - Significant reduction in lifecycle costs through decreased DCS maintenance contract fees - Flexible in-house response to screen changes and control additions - Liberation from vendor lock-in - Rapid troubleshooting with general-purpose technologies
- Company：旭化成エンジニアリング
- Price：Other
